Cargando…
Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
Osteosarcoma is the most common primary bone tumor, with a poor prognosis owing to the lack of efficient molecular-based targeted therapies. Previous studies have suggested an association between CD151 and distinct consequences in osteosarcoma tumorigenicity. However, the potential of CD151 as a the...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548188/ https://www.ncbi.nlm.nih.gov/pubmed/36209197 http://dx.doi.org/10.1186/s13578-022-00900-9 |